2[8]Lenz K,Hortnagl H,Druml W,et al.Omipressin in the treatment of functional renal failure in decompensated liver cirrhosis.Effects on renal hemodynamics and atrial natriuretic factor.Gastroenterology,1991,101:1060-1067.
3[9]Guevara M,Ginès P,Fernández-Esparrach G,et al.Reversibility of bepatorenal syndrome by prolonged administration of omipressin and plasma volume expansion.Hepatology,1998,27:35-41.
4[10]Sajiki T,Iwata H,Paek HJ,et al.Morphologic studies of hepatocytcs entrapped in hollow fibers of a bioartificial liver.ASAIO J,2000,46:49-55.
5[11]Strain AJ.Ex vivo liver cell morphogenesis:one step nearer to the bioartificial liver? Hepatology,1999,29:288-290.
6[12]Bismuth H,Figueiro J,Samuel D.What should we expect from a bioartificial liver in fulminant hepatic failure? Artif Organs,1998,22:26-31.
7[13]Ahmad J,Dodson SF,Demetris AJ,et al.Recurrent hepatitis C after liver transplantation:a nonrandomized trial of interferon aifa alone versus interferon alfa and ribavirin.Liver Transpl,2001,7:863-869.
8[14]Lavezzo B,Franchello A,Smedile A.et al.Treatment of recurrent hepatitis C in liver transplants:efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin.J Hepatol,2002,37:247-252.